If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Paolo Ubezio is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Cell Cycle Medicine & Life Sciences
trabectedin Medicine & Life Sciences
DNA Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Cells Chemical Compounds
Flow Cytometry Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
Bromodeoxyuridine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1983 2019

Combination of PPARg agonist pioglitazone and trabectedin induce adipocyte differentiation to overcome trabectedin resistance in myxoid liposarcomas

Frapolli, R., Bello, E., Ponzo, M., Craparotta, I., Mannarino, L., Ballabio, S., Marchini, S., Carrassa, L., Ubezio, P., Porcu, L., Brich, S., Sanfilippo, R., Casali, P. G., Gronchi, A., Pilotti, S. & D'Incalci, M., Dec 15 2019, In : Clinical Cancer Research. 25, 24, p. 7565-7575 11 p.

Research output: Contribution to journalArticle

trabectedin
pioglitazone
Myxoid Liposarcoma
Adipocytes
Adipogenesis

Combination of PPARg agonist pioglitazone and trabectedin induce adipocyte differentiation to overcome trabectedin resistance in myxoid liposarcomas

Frapolli, R., Bello, E., Ponzo, M., Craparotta, I., Mannarino, L., Ballabio, S., Marchini, S., Carrassa, L., Ubezio, P., Porcu, L., Brich, S., Sanfilippo, R., Casali, P. G., Gronchi, A., Pilotti, S. & D'Incalci, M., Dec 15 2019, In : Clin. Cancer Res.. 25, 24, p. 7565-7575 11 p.

Research output: Contribution to journalArticle

ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells

Portale, F., Cricrì, G., Bresolin, S., Lupi, M., Gaspari, S., Silvestri, D., Russo, B., Marino, N., Ubezio, P., Pagni, F., Vergani, P., Te Kronnie, G., Valsecchi, M. G., Locatelli, F., Rizzari, C., Biondi, A., Dander, E. & D'Amico, G., Sep 27 2018, In : Haematologica.

Research output: Contribution to journalArticle

B-Lymphoid Precursor Cells
Leukemia
Bone Marrow
Aptitude
Mesenchymal Stromal Cells

Tumor progression and metastatic dissemination in ovarian cancer after dose-dense or conventional paclitaxel and cisplatin plus bevacizumab

Bizzaro, F., Falcetta, F., D'Agostini, E., Decio, A., Minoli, L., Erba, E., Peccatori, F. A., Scanziani, E., Colombo, N., Zucchetti, M., Bani, M., Ubezio, P. & Giavazzi, R., 2018, In : International Journal of Cancer. p. 2187-2199

Research output: Contribution to journalArticle

Ovarian Neoplasms
Paclitaxel
Neoplasms
Cisplatin
Appointments and Schedules

Tumor progression and metastatic dissemination in ovarian cancer after dose-dense or conventional paclitaxel and cisplatin plus bevacizumab

Bizzaro, F., Falcetta, F., D’Agostini, E., Decio, A., Minoli, L., Erba, E., Alessandro Peccatori, F., Scanziani, E., Colombo, N., Zucchetti, M., Bani, M. R., Ubezio, P. & Giavazzi, R., 2018, In : International Journal of Cancer. 143, 9, p. 2187-2199 13 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Paclitaxel
Neoplasms
Cisplatin
Appointments and Schedules